← Evidence map

ArticleTransgender health2024

Re: "Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study" by Yaish et al.

Tomi Ruggles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Re: "Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study" by Yaish et al. | OpenQuestion